Subclinical hepatic encephalopathy impairs daily functioning

Cited in:

CrossRef

This article has been cited by:

1. 1
   Jayanta Samanta, Radha K. Dhiman, Amit Khatri, Kiran K. Thumburu, Sandeep Grover, Ajay Duseja, Yogesh Chawla, Correlation between degree and quality of sleep disturbance and the level of neuropsychiatric impairment in patients with liver cirrhosis, Metabolic Brain Disease, 2013, 28, 2, 249

   CrossRef

2. 2
   Praveen Sharma, Barjesh Chander Sharma, Disaccharides in the treatment of hepatic encephalopathy, Metabolic Brain Disease, 2013, 28, 2, 313

   CrossRef

3. 3
   Rongfeng Qi, Long Jiang Zhang, Jianhui Zhong, Zhiqiang Zhang, Ling Ni, Gang Zheng, Guang Ming Lu, Disrupted thalamic resting-state functional connectivity in patients with minimal hepatic encephalopathy, European Journal of Radiology, 2013, 82, 5, 850

   CrossRef

4. 4
   Saidan Ding, Leping Liu, Huajun Jing, Jieya Xie, Xiaobin Wang, Jinpeng Mao, Bicheng Chen, Qichuan Zhuge, Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy, Hepatology International, 2013,

   CrossRef

5. 5
   Eva Román, Juan Córdoba, Maria Torrens, Carlos Guarner, German Soriano, Falls and cognitive dysfunction impair health-related quality of life in patients with cirrhosis, European Journal of Gastroenterology & Hepatology, 2013, 25, 1, 77

   CrossRef

6. 6
   Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Nakanishi, Kaoru Tsuchiya, Takamasa Noda, Nobuharu Tamaki, Yutaka Yasui, Takanori Hosokawa, Ken Ueda, Jun Itakura, Kimitaka Anami, Yasuhiro Asahina, Nobuyuki Enomoto, Teruhiko Higuchi, Namiki Izumi, Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy, Hepatology Research, 2013, 43, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(733K)
   • References
7. 7
   Iona Coltart, Thomas H. Tranah, Debbie L. Shawcross, Inflammation and hepatic encephalopathy, Archives of Biochemistry and Biophysics, 2013,

   CrossRef

8. 8
   Natalia Arias, Marta Méndez, Camino Fidalgo, María Ángeles Aller, Jaime Arias, Jorge L. Arias, Mapping Metabolic Brain Activity in Three Models of Hepatic Encephalopathy, International Journal of Hypertension, 2013, 2013, 1

   CrossRef

9. 9
   F. J. Torlot, M. J. W. McPhail, S. D. Taylor-Robinson, Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy, Alimentary Pharmacology & Therapeutics, 2013, 37, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(275K)
   • References
10. 10
    Akinobu Kato, Hiroto Tanaka, Takumi Kawaguchi, Hidenori Kanazawa, Motoh Iwasa, Isao Sakaida, Hisataka Moriwaki, Yoshikazu Murawaki, Kazuyuki Suzuki, Kiwamu Okita, Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study, Hepatology Research, 2013, 43, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(305K)
    • References
11. 11
    Jian-Ying Liu, Jing Ding, Dong Lin, Yi-Feng He, Zhi Dai, Cai-Zhong Chen, Wei-Zhong Cheng, He Wang, Jian Zhou, Xin Wang, T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivo, Journal of Magnetic Resonance Imaging, 2013, 37, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(311K)
    • References
12. 12
    Tanja Burkard, Annette Biedermann, Christoph Herold, Michael Dietlein, Markus Rauch, Martin Diefenbach, Treatment with a potassium–iron–phosphate–citrate complex improves PSE scores and quality of life in patients with minimal hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2013, 25, 3, 352

    CrossRef

13. 13
    Matthew Tsushima, William Tsushima, Vincent Tsushima, Nelson Lim, Erika Madrigal, Christian Jackson, Michel Henry Mendler, Use of ImPACT to Diagnose Minimal Hepatic Encephalopathy: An Accurate, Practical, User-Friendly Internet-Based Neuropsychological Test Battery, Digestive Diseases and Sciences, 2013,

    CrossRef

14. 14
    Z. Poh, P. E. J. Chang, A Current Review of the Diagnostic and Treatment Strategies of Hepatic Encephalopathy, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

15. 15
    Jasmohan S. Bajaj, Patrick M. Gillevet, Neeral R. Patel, Vishwadeep Ahluwalia, Jason M Ridlon, Birgit Kettenmann, Christine M. Schubert, Masoumeh Sikaroodi, Douglas M. Heuman, Mary M. E. Crossey, Debulon E. Bell, Philip B. Hylemon, Panos P. Fatouros, Simon D. Taylor-Robinson, A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy, Metabolic Brain Disease, 2012, 27, 2, 205

    CrossRef

16. 16
    S. Montagnese, E. Amato, S. Schiff, S. Facchini, P. Angeli, A. Gatta, P. Amodio, A patients’ and caregivers’ perspective on hepatic encephalopathy, Metabolic Brain Disease, 2012, 27, 4, 567

    CrossRef

17. 17
    Hua-Jun Chen, Xi-Qi Zhu, Yun Jiao, Pei-Cheng Li, Yu Wang, Gao-Jun Teng, Abnormal baseline brain activity in low-grade hepatic encephalopathy: A resting-state fMRI study, Journal of the Neurological Sciences, 2012, 318, 1-2, 140

    CrossRef

18. 18
    R. Adrover, D. Cocozzella, E. Ridruejo, A. García, J. Rome, J. J. Podestá, Breath-Ammonia Testing of Healthy Subjects and Patients with Cirrhosis, Digestive Diseases and Sciences, 2012, 57, 1, 189

    CrossRef

19. 19
    Taofiki A. Sunmonu, Olusegun Adekanle, Morenikeji A. Komolafe, Dennis A. Ndububa, Cognitive function in patients with liver cirrhosis without overt hepatic encephalopathy: Assessment using an automated neuropsychological test battery, Arab Journal of Gastroenterology, 2012, 13, 1, 4

    CrossRef

20. 20
    Jasmohan S. Bajaj, Leroy R. Thacker, Douglas M. Heuman, Richard K. Sterling, R. Todd Stravitz, Arun J. Sanyal, Velimir Luketic, Michael Fuchs, Ho Chong S. Gilles, James B. Wade, Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: A prospective study, Liver Transplantation, 2012, 18, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(121K)
    • References
21. 21
    Vicente Felipo, Amparo Urios, Encarna Montesinos, Inmaculada Molina, Maria L. Garcia-Torres, Miguel Civera, Juan A. Olmo, Joaquin Ortega, Jose Martinez-Valls, Miguel A. Serra, Norberto Cassinello, Abdallah Wassel, Esperanza Jordá, Carmina Montoliu, Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy, Metabolic Brain Disease, 2012, 27, 1, 51

    CrossRef

22. 22
    Matthew R. Kappus, Jasmohan S. Bajaj, Covert Hepatic Encephalopathy: Not as Minimal as You Might Think, Clinical Gastroenterology and Hepatology, 2012, 10, 11, 1208

    CrossRef

23. 23
    Jasmohan S. Bajaj, Leroy R. Thacker, Douglas M. Heuman, Douglas P. Gibson, Richard K. Sterling, R. Todd Stravitz, Michael Fuchs, Arun J. Sanyal, James B. Wade, Driving Simulation Can Improve Insight into Impaired Driving Skills in Cirrhosis, Digestive Diseases and Sciences, 2012, 57, 2, 554

    CrossRef

24. 24
    Tao Li, Xin Li, Weihua Zhou, Xiaoming Cui, Lin Ma, Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy, Journal of Neuroradiology, 2012, 39, 5, 290

    CrossRef

25. 25
    J. Aguilar Reina, Encefalopatía hepática, Medicine - Programa de Formación Médica Continuada Acreditado, 2012, 11, 11, 652

    CrossRef

26. 26
    Mette Munk Lauridsen, Henning Grønbæk, Esben B. Næser, Steffen T. Leth, Hendrik Vilstrup, Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis, Metabolic Brain Disease, 2012, 27, 4, 559

    CrossRef

27. 27
    Giampaolo Bianchi, Marco Giovagnoli, Anna Simona Sasdelli, Giulio Marchesini, Hepatic Encephalopathy and Health-Related Quality of Life, Clinics in Liver Disease, 2012, 16, 1, 159

    CrossRef

28. 28
    Sunil Taneja, Radha K. Dhiman, Amit Khatri, Sandeep Goyal, Kiran K. Thumbru, Ritesh Agarwal, Ajay Duseja, Yogesh Chawla, Inhibitory Control Test for the Detection of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver, Journal of Clinical and Experimental Hepatology, 2012, 2, 4, 306

    CrossRef

29. 29
    Kevin D. Mullen, Ravi K. Prakash, Management of Covert Hepatic Encephalopathy, Clinics in Liver Disease, 2012, 16, 1, 91

    CrossRef

30. 30
    S. Montagnese, S. Schiff, M. De Rui, M. M. E. Crossey, P. Amodio, S. D. Taylor-Robinson, Neuropsychological tools in hepatology: a survival guide for the clinician, Journal of Viral Hepatitis, 2012, 19, 5

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(286K)
    • References
31. 31
    Kevin D. Mullen, Ravi K. Prakash, New Perspectives in Hepatic Encephalopathy, Clinics in Liver Disease, 2012, 16, 1, 1

    CrossRef

32. 32
    Irena Ciećko-Michalska, Małgorzata Szczepanek, Agnieszka Słowik, Tomasz Mach, Pathogenesis of Hepatic Encephalopathy, Gastroenterology Research and Practice, 2012, 2012, 1

    CrossRef

33. 33
    Vicente Felipo, Juan F. Ordoño, Amparo Urios, Nisrin El Mlili, Carla Giménez-Garzó, Carolina Aguado, Olga González-Lopez, Remedios Giner-Duran, Miguel A. Serra, Abdallah Wassel, Jose M. Rodrigo, José Salazar, Carmina Montoliu, Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests, Hepatology, 2012, 55, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(208K)
    • References
34. 34
    Rupali Singh, Pramod Kumar Sharma, Rishabha Malviya, Prebiotics: future trends in health care, Mediterranean Journal of Nutrition and Metabolism, 2012, 5, 2, 81

    CrossRef

35. 35
    Yeon Seok Seo, Sun Young Yim, Jin Yong Jung, Chang Ha Kim, Jin Dong Kim, Bora Keum, Hyonggin An, Hyung Joon Yim, Hong Sik Lee, Chang Duck Kim, Ho Sang Ryu, Soon Ho Um, Psychometric Hepatic Encephalopathy Score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis, Journal of Gastroenterology and Hepatology, 2012, 27, 11

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(545K)
    • References
36. 36
    Ki Tae Suk, Soon Koo Baik, Jung Hwan Yoon, Jae Youn Cheong, Yong Han Paik, Chang Hyeong Lee, Young Seok Kim, Jin Woo Lee, Dong Joon Kim, Sung Won Cho, Seong Gyu Hwang, Joo Hyun Sohn, Moon Young Kim, Young Bae Kim, Jae Geun Kim, Yong Kyun Cho, Moon Seok Choi, Hyung Joon Kim, Hyun Woong Lee, Seung Up Kim, Ja Kyung Kim, Jin Young Choi, Dae Won Jun, Won Young Tak, Byung Seok Lee, Byoung Kuk Jang, Woo Jin Chung, Hong Soo Kim, Jae Young Jang, Soung Won Jeong, Sang Gyune Kim, Oh Sang Kwon, Young Kul Jung, Won Hyeok Choe, June Sung Lee, In Hee Kim, Jae Jun Shim, Gab Jin Cheon, Si Hyun Bae, Yeon Seok Seo, Dae Hee Choi, Se Jin Jang, Revision and update on clinical practice guideline for liver cirrhosis, The Korean Journal of Hepatology, 2012, 18, 1, 1

    CrossRef

37. 37
    Hua-Jun Chen, Yu Wang, Xi-Qi Zhu, Ying Cui, Yu-Chen Chen, Gao-Jun Teng, White matter abnormalities correlate with neurocognitive performance in patients with HBV-related cirrhosis, Journal of the Neurological Sciences, 2012, 321, 1-2, 65

    CrossRef

38. 38
    Carmina Montoliu, Omar Cauli, Amparo Urios, Nisrin ElMlili, Miguel A Serra, Remedios Giner-Duran, Olga González-Lopez, Juan A Del Olmo, Abdallah Wassel, Jose M Rodrigo, Vicente Felipo, 3-Nitro-Tyrosine as a Peripheral Biomarker of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis, The American Journal of Gastroenterology, 2011, 106, 9, 1629

    CrossRef

39. 39
    Vibhu Vibhas Mittal, Barjesh Chander Sharma, Praveen Sharma, Shiv Kumar Sarin, A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2011, 23, 8, 725

    CrossRef

40. 40
    Mariano Malaguarnera, Rita Bella, Marco Vacante, Maria Giordano, Giulia Malaguarnera, Maria Pia Gargante, Massimo Motta, Antonio Mistretta, Liborio Rampello, Giovanni Pennisi, Acetyl-l-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy, Scandinavian Journal of Gastroenterology, 2011, 46, 6, 750

    CrossRef

41. 41
    Jennifer Y. Montgomery, Jasmohan S. Bajaj, Advances in the Evaluation and Management of Minimal Hepatic Encephalopathy, Current Gastroenterology Reports, 2011, 13, 1, 26

    CrossRef

42. 42
    Mette Munk Lauridsen, Peter Jepsen, Hendrik Vilstrup, Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy. A comparative study of 154 patients with liver disease, Metabolic Brain Disease, 2011, 26, 2, 135

    CrossRef

43. 43
    Ravi K. Prakash, Kevin D. Mullen, Is poor quality of life always present with minimal hepatic encephalopathy?, Liver International, 2011, 31, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(100K)
    • References
44. You have free access to this content44
    S. Shukla, A. Shukla, S. Mehboob, S. Guha, Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy, Alimentary Pharmacology & Therapeutics, 2011, 33, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(274K)
    • References
45. 45
    Ewa Wunsch, Barbara Szymanik, Michał Post, Wojciech Marlicz, Marta Mydłowska, Piotr Milkiewicz, Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study, Liver International, 2011, 31, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(151K)
    • References
46. 46
    Juan Córdoba, New assessment of hepatic encephalopathy, Journal of Hepatology, 2011, 54, 5, 1030

    CrossRef

47. 47
    Janus P. Ong, Gerd Oehler, Christiane Krüger-Jansen, Judith Lambert-Baumann, Zobair M. Younossi, Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy, Clinical Drug Investigation, 2011, 31, 4, 213

    CrossRef

48. 48
    Dileep K Atluri, Ravi Prakash, Kevin D Mullen, Pathogenesis, Diagnosis, and Treatment of Hepatic Encephalopathy, Journal of Clinical and Experimental Hepatology, 2011, 1, 2, 77

    CrossRef

49. 49
    Federica Moscucci, Silvia Nardelli, Ilaria Pentassuglio, Chiara Pasquale, Lorenzo Ridola, Manuela Merli, Oliviero Riggio, Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients, Liver International, 2011, 31, 10

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(194K)
    • References
50. 50
    J. S. Bajaj, L. R. Thacker, J. B. Wade, A. J. Sanyal, D. M. Heuman, R. K. Sterling, D. P. Gibson, R. T. Stravitz, P. Puri, M. Fuchs, V. Luketic, N. Noble, M. White, D. Bell, D. A. Revicki, PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis, Alimentary Pharmacology & Therapeutics, 2011, 34, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(135K)
    • References
51. 51
    Jasmohan S. Bajaj, Douglas M. Heuman, James B. Wade, Douglas P. Gibson, Kia Saeian, Jacob A. Wegelin, Muhammad Hafeezullah, Debulon E. Bell, Richard K. Sterling, R. Todd Stravitz, Michael Fuchs, Velimir Luketic, Arun J. Sanyal, Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy, Gastroenterology, 2011, 140, 2, 478

    CrossRef

52. 52
    Sandeep Singh Sidhu, Omesh Goyal, Bholeshwar Prashad Mishra, Ajit Sood, Rajoo Singh Chhina, Ravinder Kumar Soni, Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial), The American Journal of Gastroenterology, 2011, 106, 2, 307

    CrossRef

53. 53
    Yahia Z. Gad, Ashraf A. Zaher, Nasser H. Moussa, Abd-Elmohsen E. El-desoky, Hala A. Al-Adarosy, Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis, Arab Journal of Gastroenterology, 2011, 12, 2, 58

    CrossRef

54. 54
    Kojiro Michitaka, Atsushi Hiraoka, Misaki Kume, Takahide Uehara, Satoshi Hidaka, Tomoyuki Ninomiya, Aki Hasebe, Yasunao Miyamoto, Misa Ichiryu, Tetsuya Tanihira, Hiromasa Nakahara, Hironori Ochi, Atsushi Tanabe, Kazuhiro Uesugi, Yoshio Tokumoto, Toshie Mashiba, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji, Amino acid imbalance in patients with chronic liver diseases, Hepatology Research, 2010, 40, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(191K)
    • References
55. 55
    S. K. Yadav, S. Saksena, A. Srivastava, A. Srivastava, V. A. Saraswat, M. A. Thomas, R. K. S. Rathore, R. K. Gupta, Brain MR Imaging and 1H-MR Spectroscopy Changes in Patients with Extrahepatic Portal Vein Obstruction from Early Childhood to Adulthood, American Journal of Neuroradiology, 2010, 31, 7, 1337

    CrossRef

56. 56
    Amit Goel, Santosh Yadav, Vivek Saraswat, Arti Srivastava, M. Albert Thomas, Chandra M. Pandey, Ramkishore Rathore, Rakesh Gupta, Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction, Liver International, 2010, 30, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(268K)
    • References
57. 57
    Thomas D. Schiano, Clinical Management of Hepatic Encephalopathy, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 5P2

    Direct Link:

    • Abstract
    • PDF(112K)
    • References
58. 58
    Radha K. Dhiman, Roshan Kurmi, Kiran K. Thumburu, Sunil H. Venkataramarao, Ritesh Agarwal, Ajay Duseja, Yogesh Chawla, Diagnosis and Prognostic Significance of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver, Digestive Diseases and Sciences, 2010, 55, 8, 2381

    CrossRef

59. 59
    Neville Bamji, Lawrence B. Cohen, Endoscopic Sedation of Patients with Chronic Liver Disease, Clinics in Liver Disease, 2010, 14, 2, 185

    CrossRef

60. 60
    Luis Compañy, Pedro Zapater, Miguel Pérez-Mateo, Rodrigo Jover, Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis, European Journal of Gastroenterology & Hepatology, 2010, 22, 5, 519

    CrossRef

61. 61
    A. Tryc, A. Goldbecker, K. Weissenborn, Hepatische Enzephalopathie, Intensivmedizin und Notfallmedizin, 2010, 47, 8, 553

    CrossRef

62. 62
    Piero Amodio, Lorenzo Ridola, Sami Schiff, Sara Montagnese, Chiara Pasquale, Silvia Nardelli, Ilaria Pentassuglio, Maria Trezza, Chiara Marzano, Cristiana Flaiban, Paolo Angeli, Giorgia Cona, Patrizia Bisiacchi, Angelo Gatta, Oliviero Riggio, Improving the Inhibitory Control Task to Detect Minimal Hepatic Encephalopathy, Gastroenterology, 2010, 139, 2, 510

    CrossRef

63. 63
    Ravi Prakash, Kevin D. Mullen, Mechanisms, diagnosis and management of hepatic encephalopathy, Nature Reviews Gastroenterology & Hepatology, 2010, 7, 9, 515

    CrossRef

64. You have free access to this content64
    Radha K Dhiman, Vivek A Saraswat, Barjesh K Sharma, Shiv K Sarin, Yogesh K Chawla, Roger Butterworth, Ajay Duseja, Rakesh Aggarwal, Deepak Amarapurkar, Praveen Sharma, Kaushal Madan, Samir Shah, Avnish K Seth, Rakesh K Gupta, Abraham Koshy, Ramesh R Rai, Jang B. Dilawari, Sri Prakash Mishra, Subrat K Acharya, Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver, Journal of Gastroenterology and Hepatology, 2010, 25, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(238K)
    • References
65. 65
    Francesca Campagna, A. Biancardi, U. Cillo, A. Gatta, P. Amodio, Neurocognitive-neurological complications of liver transplantation: a review, Metabolic Brain Disease, 2010, 25, 1, 115

    CrossRef

66. 66
    Iñigo Les, Eduardo Doval, Montserrat Flavià, Carlos Jacas, Guillermo Cárdenas, Rafael Esteban, Jaime Guardia, Juan Córdoba, Quality of life in cirrhosis is related to potentially treatable factors, European Journal of Gastroenterology & Hepatology, 2010, 22, 2, 221

    CrossRef

67. 67
    Kevin Mullen, Ravi Prakash, Rifaximin for the treatment of hepatic encephalopathy, Expert Review of Gastroenterology & Hepatology, 2010, 4, 6, 665

    CrossRef

68. 68
    Florian Krismer, Jonathan C. P. Roos, Melanie Schranz, Ivo W. Graziadei, Sergei Mechtcheriakov, Wolfgang Vogel, R. H. S. Carpenter, Heinz Zoller, Saccadic latency in hepatic encephalopathy: a pilot study, Metabolic Brain Disease, 2010, 25, 3, 285

    CrossRef

69. 69
    J. Richard Thompson, Treatment Guidelines for Hepatic Encephalopathy, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 5P2

    Direct Link:

    • Abstract
    • PDF(117K)
    • References
70. 70
    Marta Méndez, Magdalena Méndez-López, Laudino López, María Ángeles Aller, Jaime Arias, Jorge L. Arias, Basal and learning task-related brain oxidative metabolism in cirrhotic rats, Brain Research Bulletin, 2009, 78, 4-5, 195

    CrossRef

71. 71
    Amparo Amorós, José R. Aparicio, Marta Garmendia, Juan A. Casellas, Juan Martínez, Rodrigo Jover, Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy, Gastrointestinal Endoscopy, 2009, 70, 2, 262

    CrossRef

72. 72
    Ying-qun Zhou, Shi-yao Chen, Lin-di Jiang, Chuan-yong Guo, Zhen-yu Shen, Pei-xing Huang, Ji-yao Wang, Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy, Journal of Gastroenterology and Hepatology, 2009, 24, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(134K)
    • References
73. 73
    Piero Amodio, Health related quality of life and minimal hepatic encephalopathy. It is time to insert ‘quality’ in health care, Journal of Gastroenterology and Hepatology, 2009, 24, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(61K)
    • References
74. 74
    Yasemen Eroglu, William J. Byrne, Hepatic Encephalopathy, Emergency Medicine Clinics of North America, 2009, 27, 3, 401

    CrossRef

75. 75
    Gerald Kircheis, Anja Knoche, Norbert Hilger, Frank Manhart, Alfons Schnitzler, Horst Schulze, Dieter Häussinger, Hepatic Encephalopathy and Fitness to Drive, Gastroenterology, 2009, 137, 5, 1706

    CrossRef

76. 76
    Carmina Montoliu, Blanca Piedrafita, Miguel A. Serra, Juan A. del Olmo, Amparo Urios, Jose M. Rodrigo, Vicente Felipo, IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy, Journal of Clinical Gastroenterology, 2009, 43, 3, 272

    CrossRef

77. 77
    Pilar Monfort, Omar Cauli, Carmina Montoliu, Regina Rodrigo, Marta Llansola, Blanca Piedrafita, Nisrin el Mlili, Jordi Boix, Ana Agustí, Vicente Felipo, Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: Therapeutical implications, Neurochemistry International, 2009, 55, 1-3, 106

    CrossRef

78. 78
    Radha K. Dhiman, Yogesh K. Chawla, Minimal hepatic encephalopathy, Indian Journal of Gastroenterology, 2009, 28, 1, 5

    CrossRef

79. 79
    Jasmohan S. Bajaj, Kia Saeian, Christine M. Schubert, Muhammad Hafeezullah, Jose Franco, Rajiv R. Varma, Douglas P. Gibson, Raymond G. Hoffmann, R. Todd Stravitz, Douglas M. Heuman, Richard K. Sterling, Mitchell Shiffman, Allyne Topaz, Sherry Boyett, Debulon Bell, Arun J. Sanyal, Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test, Hepatology, 2009, 50, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(378K)
    • References
80. 80
    Praveen Sharma, Barjesh Chander Sharma, Vinod Puri, Shiv Kumar Sarin, Natural History of Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction, The American Journal of Gastroenterology, 2009, 104, 4, 885

    CrossRef

81. 81
    Monika Schmid, Christian Mittermaier, Bernhard Voller, Veronika Fialka-Moser, Alfred Gangl, Markus Peck-Radosavljevic, Postural control in patients with liver cirrhosis: a posturographic study, European Journal of Gastroenterology & Hepatology, 2009, 21, 8, 915

    CrossRef

82. 82
    Y. CHAWLA, A. DUSEJA, R. K. DHIMAN, Review article: the modern management of portal vein thrombosis, Alimentary Pharmacology & Therapeutics, 2009, 30, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(126K)
    • References
83. 83
    Praveen Sharma, Barjesh C. Sharma, Vinod Puri, Shiv Kumar Sarin, An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2008, 20, 6, 506

    CrossRef

84. 84
    Piero Amodio, Francesca Campagna, Stefania Olianas, Pamela Iannizzi, Daniela Mapelli, Marco Penzo, Paolo Angeli, Angelo Gatta, Detection of minimal hepatic encephalopathy: Normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study, Journal of Hepatology, 2008, 49, 3, 346

    CrossRef

85. 85
    Akinobu Kato, Yuki Watanabe, Kei Sawara, Kazuyuki Suzuki, Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests), Hepatology Research, 2008, 38,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(72K)
    • References
86. 86
    Jasmohan S. Bajaj, Muhammad Hafeezullah, Jose Franco, Rajiv R. Varma, Raymond G. Hoffmann, Joshua F. Knox, Darrell Hischke, Thomas A. Hammeke, Steven D. Pinkerton, Kia Saeian, Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy, Gastroenterology, 2008, 135, 5, 1591

    CrossRef

87. 87
    Tarek I. Hassanein, Robin C. Hilsabeck, William Perry, Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA), Digestive Diseases and Sciences, 2008, 53, 2, 529

    CrossRef

88. 88
    Kola Hisamuddin, Satish Iduru, Kevin D Mullen, Is the inhibitory control test as accurate as standard psychometric testing for diagnosing hepatic encephalopathy?, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5, 3, 132

    CrossRef

89. 89
    Jasmohan S Bajaj, Management options for minimal hepatic encephalopathy, Expert Review of Gastroenterology & Hepatology, 2008, 2, 6, 785

    CrossRef

90. 90
    Praveen Sharma, Barjesh C. Sharma, Vinod Puri, Shiv K. Sarin, Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction, The American Journal of Gastroenterology, 2008, 103, 6, 1406

    CrossRef

91. 91
    Jasmohan S. Bajaj, Muhammad Hafeezullah, Raymond G. Hoffmann, Rajiv R. Varma, Jose Franco, David G. Binion, Thomas A. Hammeke, Kia Saeian, Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy, Hepatology, 2008, 47, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(302K)
    • References
92. 92
    Charles H. Hinkin, Steven A. Castellon, Andrew J. Levine, Terry R. Barclay, Elyse J. Singer, Neurocognition in Individuals Co-Infected with HIV and Hepatitis C, Journal of Addictive Diseases, 2008, 27, 2, 11

    CrossRef

93. 93
    Kojiro Michitaka, Yoshio Tokumoto, Kazuhiro Uesugi, Yoshiyasu Kisaka, Masashi Hirooka, Ichiro Konishi, Toshie Mashiba, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Norio Horiike, Takaaki Shoda, Morikazu Onji, Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis, Hepatology Research, 2008, 38, 11

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(81K)
    • References
94. 94
    Jasmohan S. Bajaj, Kia Saeian, Kenneth M. Christensen, Muhammad Hafeezullah, Rajiv R. Varma, Jose Franco, Joan A. Pleuss, Glenn Krakower, Raymond G. Hoffmann, David G. Binion, Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy, The American Journal of Gastroenterology, 2008, 103, 7, 1707

    CrossRef

95. 95
    Ryosuke Sugimoto, Motoh Iwasa, Masayuki Maeda, Naohito Urawa, Hideaki Tanaka, Naoki Fujita, Yoshinao Kobayashi, Kan Takeda, Masahiko Kaito, Yoshiyuki Takei, Value of the Apparent Diffusion Coefficient for Quantification of Low-Grade Hepatic Encephalopathy, The American Journal of Gastroenterology, 2008, 103, 6, 1413

    CrossRef

96. 96
    Marta Méndez, Magdalena Méndez-López, Laudino López, María A. Aller, Jaime Arias, Jorge L. Arias, Working memory impairment and reduced hippocampal and prefrontal cortex c-Fos expression in a rat model of cirrhosis, Physiology & Behavior, 2008, 95, 3, 302

    CrossRef

97. 97
    Carmina Montoliu, Blanca Piedrafita, Miguel A. Serra, Juan A. Olmo, Antonio Ferrandez, José M. Rodrigo, Vicente Felipo, Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients, Journal of Molecular Medicine, 2007, 85, 3, 237

    CrossRef

98. 98
    Gerald Kircheis, Wolfgang E. Fleig, Roman Görtelmeyer, Susanne Grafe, Dieter Häussinger, Assessment of low-grade hepatic encephalopathy: A critical analysis, Journal of Hepatology, 2007, 47, 5, 642

    CrossRef

99. 99
    Asif M. Qadri, Ben O. Ogunwale, Kevin D. Mullen, Can we ignore minimal hepatic encephalopathy any longer?, Hepatology, 2007, 45, 3

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(48K)
    • References
100. 100
     P. Sharma, B.C. Sharma, V. Puri, S.K. Sarin, Critical flicker frequency: Diagnostic tool for minimal hepatic encephalopathy, Journal of Hepatology, 2007, 47, 1, 67

     CrossRef

101. 101
     Manuel Romero-Gómez, Critical flicker frequency: It is time to break down barriers surrounding minimal hepatic encephalopathy, Journal of Hepatology, 2007, 47, 1, 10

     CrossRef

102. 102
     G. Kircheis, Hepatische Enzephalopathie, Der Gastroenterologe, 2007, 2, 4, 251

     CrossRef

103. 103
     Laurent Spahr, Alessandra Coeytaux, Emiliano Giostra, Antoine Hadengue, Jean-Marie Annoni, Histamine H1 Blocker Hydroxyzine Improves Sleep in Patients With Cirrhosis and Minimal Hepatic Encephalopathy: A Randomized Controlled Pilot Trial, The American Journal of Gastroenterology, 2007, 102, 4, 744

     CrossRef

104. 104
     Jasmohan S Bajaj, Kia Saeian, Matthew D Verber, Darrell Hischke, Raymond G Hoffmann, Jose Franco, Rajiv R Varma, Stephen M Rao, Inhibitory Control Test Is a Simple Method to Diagnose Minimal Hepatic Encephalopathy and Predict Development of Overt Hepatic Encephalopathy, The American Journal of Gastroenterology, 2007, 102, 4, 754

     CrossRef

105. 105
     Srinivasa Prasad, Radha K. Dhiman, Ajay Duseja, Yogesh K. Chawla, Arpita Sharma, Ritesh Agarwal, Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy, Hepatology, 2007, 45, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(281K)
     • References
106. 106
     Evangelos Kalaitzakis, Einar Björnsson, Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life, Hepatology, 2007, 46, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(51K)
107. 107
     Kola Hisamuddin, Kevin D. Mullen, LIVING UNDER THE INFLUENCE OF MINIMAL HEPATIC ENCEPHALOPATHY!, Evidence-Based Gastroenterology, 2007, 8, 4, 77

     CrossRef

108. 108
     Vincenzo Citro, Graziella Milan, Francesca Saveria Tripodi, Antonio Gennari, Paolo Sorrentino, Giovanni Gallotta, Alfredo Postiglione, Giovanni Tarantino, Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection, Journal of Gastroenterology, 2007, 42, 1, 79

     CrossRef

109. 109
     Charmaine A Stewart, Glenn E Smith, Minimal hepatic encephalopathy, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 12, 677

     CrossRef

110. 110
     Jasmohan S. Bajaj, Muhammad Hafeezullah, Raymond G. Hoffmann, Kia Saeian, Minimal Hepatic Encephalopathy: A Vehicle for Accidents and Traffic Violations, The American Journal of Gastroenterology, 2007, 102, 9, 1903

     CrossRef

111. 111
     Omar Cauli, Nisrin Mlili, Marta Llansola, Vicente Felipo, Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats, European Journal of Neuroscience, 2007, 25, 7

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(817K)
     • References
112. 112
     F. F. POORDAD, Review article: the burden of hepatic encephalopathy, Alimentary Pharmacology & Therapeutics, 2007, 25,

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(129K)
     • References
113. 113
     Sara Montagnese, Clive Jackson, Marsha Y. Morgan, Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis, Journal of Hepatology, 2007, 46, 3, 447

     CrossRef

114. 114
     Jasmohan Singh Bajaj, Ashkan Etemadian, Muhammad Hafeezullah, Kia Saeian, Testing for minimal hepatic encephalopathy in the United States: An AASLD survey, Hepatology, 2007, 45, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(59K)
115. 115
     E. HUANG, E. ESRAILIAN, B. M. R. SPIEGEL, The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy – a decision analysis, Alimentary Pharmacology & Therapeutics, 2007, 26, 8

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(240K)
     • References
116. 116
     Manuel Romero-Gómez, Juan Córdoba, Rodrigo Jover, Juan A. del Olmo, Marta Ramírez, Ramón Rey, Enrique de Madaria, Carmina Montoliu, David Nuñez, Montse Flavia, Luis Compañy, José M. Rodrigo, Vicente Felipo, Value of the critical flicker frequency in patients with minimal hepatic encephalopathy, Hepatology, 2007, 45, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(195K)
     • References
117. 117
     Brian P. Bosworth, Brian R. Landzberg, Neurobiology of Disease, 2007,

     CrossRef

118. 118
     Hanan Al Mardini, Andrew Douglass, Christopher Record, Amino Acid Challenge in Patients with Cirrhosis and Control Subjects: Ammonia, Plasma Amino Acid and EEG Changes, Metabolic Brain Disease, 2006, 21, 1, 1

     CrossRef

119. 119
     D. Pascoli, J.M. Guérit, S. Montagnese, M. de Tourtchaninoff, T. Minelli, A. Pellegrini, F. Del Piccolo, A. Gatta, P. Amodio, Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy, Computer Methods and Programs in Biomedicine, 2006, 81, 3, 203

     CrossRef

120. 120
     Samuel H. Sigal, Carmen M. Stanca, Nickolas Kontorinis, Carol Bodian, Elizabeth Ryan, Diabetes Mellitus Is Associated with Hepatic Encephalopathy in Patients with HCV Cirrhosis, The American Journal of Gastroenterology, 2006, 101, 7, 1490

     CrossRef

121. 121
     Juan C. Quero Guillén, Juan M. Herrerías Gutiérrez, Diagnostic methods in hepatic encephalopathy, Clinica Chimica Acta, 2006, 365, 1-2, 1

     CrossRef

122. 122
     M. Vergara-Gómez, M. Flavià-Olivella, M. Gil-Prades, B. Dalmau-Obrador, J. Córdoba-Cardona, Diagnóstico y tratamiento de la encefalopatía hepática en España: resultados de una encuesta dirigida a hepatólogos, Gastroenterología y Hepatología, 2006, 29, 1, 1

     CrossRef

123. 123
     T. Meyer, A. Eshelman, M. Abouljoud, Neuropsychological Changes in a Large Sample of Liver Transplant Candidates, Transplantation Proceedings, 2006, 38, 10, 3559

     CrossRef

124. 124
     Beatriz Mínguez, Juan Carlos García-Pagán, Jaume Bosch, Juan Turnes, Juli Alonso, Alex Rovira, Juan Córdoba, Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy, Hepatology, 2006, 43, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(162K)
     • References
125. 125
     Freimut Schliess, Boris Görg, Dieter Häussinger, Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm, Biological Chemistry, 2006, 387, 10/11

     CrossRef

126. 126
     Slaven Erceg, Pilar Monfort, Omar Cauli, Carmina Montoliu, Marta Llansola, Blanca Piedrafita, Vicente Felipo, Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure, Neurochemistry International, 2006, 48, 6-7, 441

     CrossRef

127. 127
     Irene Nikaina, Chaido Pastaka, Kalliopi Zachou, Georgios N. Dalekos, Kostantinos Gourgoulianis, Sleep apnoea syndrome and early stage cirrhosis: a pilot study, European Journal of Gastroenterology & Hepatology, 2006, 18, 1, 31

     CrossRef

128. 128
     Fredrik C. Kugelberg, Gustav Apelqvist, Björn Carlsson, Johan Ahlner, Finn Bengtsson, Sustained Citalopram Treatment in Experimental Hepatic Encephalopathy: Effects on Entrainment to the Light-Dark Cycle and Melatonin, Basic & Clinical Pharmacology & Toxicology, 2006, 99, 1

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(180K)
     • References
129. 129
     Manuel Romero Gómez, Juan Córdoba, Rodrigo Jover, Juan del Olmo, Ana Fernández, Montse Flavià, Luis Compañy, María José Poveda, Vicente Felipo, Tablas de normalidad de la población española para los tests psicométricos utilizados en el diagnóstico de la encefalopatía hepática mínima, Medicina Clínica, 2006, 127, 7, 246

     CrossRef

130. 130
     Alexander Collie, Cognition in liver disease, Liver International, 2005, 25, 1

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(122K)
     • References
131. 131
     Katia Mattarozzi, Claudio Campi, Maria Guarino, Andrea Stracciari, Distinguishing Between Clinical and Minimal Hepatic Encephalopathy on the Basis of Specific Cognitive Impairment, Metabolic Brain Disease, 2005, 20, 3, 243

     CrossRef

132. 132
     Ger Bongaerts, René Severijnen, Harro Timmerman, Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy, Medical Hypotheses, 2005, 64, 1, 64

     CrossRef

133. 133
     María Ortiz, Carlos Jacas, Juan Córdoba, Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations, Journal of Hepatology, 2005, 42, 1, S45

     CrossRef

134. 134
     Piero Amodio, Angelo Gatta, Neurophysiological Investigation of Hepatic Encephalopathy, Metabolic Brain Disease, 2005, 20, 4, 369

     CrossRef

135. 135
     Fasiha Kanwal, Ron D. Hays, Amy M. Kilbourne, Gareth S. Dulai, Ian M. Gralnek, Are Physician-Derived Disease Severity Indices Associated with Health-Related Quality of Life in Patients with End-Stage Liver Disease?, The American Journal of Gastroenterology, 2004, 99, 9, 1726

     CrossRef

136. 136
     Juan Córdoba, Roy Lucke, Driving under the influence of minimal hepatic encephalopathy, Hepatology, 2004, 39, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(63K)
     • References
137. 137
     M. Durán Tabernes, J. Córdoba Cardona, Encefalopatía hepática, Medicine - Programa de Formación Médica Continuada Acreditado, 2004, 9, 8, 513

     CrossRef

138. 138
     Sergei Mechtcheriakov, Ivo W. Graziadei, Michael Mattedi, Thomas Bodner, André Kugener, Hartmann H. Hinterhuber, Josef Marksteiner, Wolfgang Vogel, Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation, Liver Transplantation, 2004, 10, 1

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(87K)
     • References
139. 139
     Christian Wein, Horst Koch, Birthe Popp, Gerd Oehler, Peter Schauder, Minimal hepatic encephalopathy impairs fitness to drive, Hepatology, 2004, 39, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(117K)
     • References
140. 140
     Oliver Zafiris, Gerald Kircheis, Hermann A Rood, Frank Boers, Dieter Häussinger, Karl Zilles, Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study, NeuroImage, 2004, 22, 2, 541

     CrossRef

141. 141
     Manuel Romero-Gómez, Lourdes Grande, Inés Camacho, Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy, Hepatology, 2004, 39, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(112K)
     • References
142. 142
     Angelo Zullo, Cesare Hassan, Sergio Morini, Hepatic Encephalopathy and Helicobacter pylori, Journal of Clinical Gastroenterology, 2003, 37, 2, 164

     CrossRef

143. 143
     S.F Solga, Probiotics can treat hepatic encephalopathy, Medical Hypotheses, 2003, 61, 2, 307

     CrossRef

144. 144
     Juan Córdoba, Montse Flavià, Carlos Jacas, Silvia Sauleda, Juan Ignacio Esteban, Vı́ctor Vargas, Rafael Esteban, Jaume Guardia, Quality of life and cognitive function in hepatitis C at different stages of liver disease, Journal of Hepatology, 2003, 39, 2, 231

     CrossRef

145. 145
     M. Lewis, P.D. Howdle, The neurology of liver failure, QJM, 2003, 96, 9, 623

     CrossRef

146. 146
     Jörg B. Schulz, Allen I. Arieff, Neurological Disorders, 2003,

     CrossRef

147. 147
     Manuel Romero-Gómez, Lourdes Grande, Inés Camacho, Soledad Benitez, José A Irles, Manuel Castro, Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy, Journal of Hepatology, 2002, 37, 6, 781

     CrossRef

148. 148
     Nandini Saxena, Manvir Bhatia, Yogendra K. Joshi, Pramod K. Garg, Sada Nand Dwivedi, Rakesh K. Tandon, Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy, Liver, 2002, 22, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(104K)
     • References
149. 149
     Alan H Lockwood, Hepatic Encephalopathy, Neurologic Clinics, 2002, 20, 1, 241

     CrossRef

150. 150
     Gülseren Ünal, Josien B de Boer, Gerard J.J.M Borsboom, Johannes T Brouwer, Marie-Louise Essink-Bot, Robert A de Man, A psychometric comparison of health-related quality of life measures in chronic liver disease, Journal of Clinical Epidemiology, 2001, 54, 6, 587

     CrossRef

151. 151
     Andrew Douglass, Hanan Al Mardini, Christopher Record, Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy, Journal of Hepatology, 2001, 34, 5, 658

     CrossRef

152. 152
     Janus P. Ong, Kevin D. Mullen, Hepatic encephalopathy, European Journal of Gastroenterology & Hepatology, 2001, 13, 4, 325

     CrossRef

153. 153
     Karin Weissenborn, Jochen C Ennen, Hans Schomerus, Norbert Rückert, Hartmut Hecker, Neuropsychological characterization of hepatic encephalopathy, Journal of Hepatology, 2001, 34, 5, 768

     CrossRef

154. 154
     Ananya Das, Radha K Dhiman, Vivek A Saraswat, Meera Verma, Subhash R Naik, Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis, Journal of Gastroenterology and Hepatology, 2001, 16, 5

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(61K)
     • References
155. 155
     Piero Amodio, Franco Del Piccolo, Elena Pettenò, Daniela Mapelli, Paolo Angeli, Rosamaria Iemmolo, Maurizio Muraca, Carmine Musto, Giorgio Gerunda, Cristiano Rizzo, Carlo Merkel, Angelo Gatta, Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients, Journal of Hepatology, 2001, 35, 1, 37

     CrossRef

156. 156
     Manuel Romero-Gomez, Fernando Boza, Maria Sierra Garci'a-Valdecasas, Emilio Garci'a, Jose Aguilar-Reina, Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy, The American Journal of Gastroenterology, 2001, 96, 9, 2718

     CrossRef

157. 157
     P Amodio, L Caregaro, E Pettenó, M Marcon, F DelPiccolo, A Gatta, Vegetarian diets in hepatic encephalopathy: facts or fantasies?, Digestive and Liver Disease, 2001, 33, 6, 492

     CrossRef

158. 158
     Alan H. Lockwood, “;What's in a name?” Improving the care of cirrhotics, Journal of Hepatology, 2000, 32, 5, 859

     CrossRef

159. 159
     Andres T Blei, Diagnosis and treatment of hepatic encephalopathy, Best Practice & Research Clinical Gastroenterology, 2000, 14, 6, 959

     CrossRef

160. 160
     Gustav Apelqvist, Cecilia Wikell, Bj??rn Carlsson, Stephan Hjorth, Peter B.F. Bergqvist, Johan Ahlner, Finn Bengtsson, Dynamic and Kinetic Effects of Chronic Citalopram Treatment in Experimental Hepatic Encephalopathy, Clinical Neuropharmacology, 2000, 23, 6, 304

     CrossRef

161. 161
     J. González-Abraldes, A. Mas, Encefalopatía hepática. patogenia y formas clínicas, Medicine - Programa de Formación Médica Continuada Acreditado, 2000, 8, 10, 508

     CrossRef

162. 162
     Michael Groeneweg, Wendy Moerland, Juan C Quero, Wim C.J Hop, Paul F Krabbe, Solko W Schalm, Screening of subclinical hepatic encephalopathy, Journal of Hepatology, 2000, 32, 5, 748

     CrossRef

163. 163
     Jean-Michel Guérit, Piero Amodio, Hava Hafner, Gerard Litscher, A.C. Van Huffelen, Clinical Neurophysiology at the Beginning of the 21st Century, 11th International Congress of Electromyography and Clinical Neurophysiology, 2000,

     CrossRef

164. 164
     David Edwin, Laura Flynn, Andrew Klein, Paul J. Thuluvath, Cognitive impairment in alcoholic and nonalcoholic cirrhotic patients, Hepatology, 1999, 30, 6

     Direct Link:

     • Abstract
     • PDF(69K)
     • References
165. 165
     Angelo Zullo, Vittorio Rinaldi, Patrizia Meddi, Cesare Hassan, Simon Winn, Adolfo F. Attili, Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients, The American Journal of Gastroenterology, 1999, 94, 8, 2214

     CrossRef

166. 166
     Thomas A. Brown, Kevin D. Mullen, Hepatic Encephalopathy,

     Direct Link:

     • Summary
     • PDF(127K)
     • References
167. 167
     Marsha Y. Morgan, Hepatic Encephalopathy in Patients with Cirrhosis,

     Direct Link:

     • Summary
     • PDF(2472K)
     • References
168. 168
     Peter Ferenci, Christian Müller, Hepatic Encephalopathy: Treatment,

     Direct Link:

     • Summary
     • PDF(573K)
     • References
169. 169
     Richard McGee, Kerrie Wiley, Stephen M Riordan, Angela C Webster, Probiotics for hepatic encephalopathy, The Cochrane Library,

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(148K)
     • References
170. 170
     Richard G McGee, Anouk Bakens, Kerrie Wiley, Stephen M Riordan, Angela C Webster, Probiotics for patients with hepatic encephalopathy, The Cochrane Library,

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(738K)
     • References